Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
Advertisement
SureTrader Stock Hero Advertisement
Home > Boards > US OTC > Medical - Drugs > Ocata Therapeutics Inc. (OCAT)

Advanced Cell Technology Shelves Myoblast Program...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ddls Member Profile
 
Followed By 22
Posts 8,718
Boards Moderated 0
Alias Born 06/18/09
160x600 placeholder
Ocata Therapeutics Licenses Induced Pluripotent Stem Cell Technology from Allele Biotechnology & Extends Leadership Position ... "Business Wire" - 3/24/2015 9:05:00 AM
Ocata Therapeutics Receives Regulatory Guidance from European Medicines Agency "Business Wire" - 3/17/2015 9:02:00 AM
Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the Fourth Quarter and Full Year of 2014 "Business Wire" - 3/11/2015 9:01:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/9/2015 4:20:31 PM
Ocata Therapeutics To Trade On Nasdaq Global Market: Can The Bulls Finally Rejoice? "Seeking Alpha" - 2/26/2015 9:33:29 PM
Ocata Therapeutics Approved for Listing on NASDAQ "Business Wire" - 2/26/2015 9:02:00 AM
Ocata Therapeutics Receives Two New Patents for Immune-modulatory Cell Technology "Business Wire" - 2/25/2015 9:01:00 AM
Ocata Therapeutics to Present at 2015 Cowen Health Care Conference "Business Wire" - 2/24/2015 9:14:00 AM
Ocata Therapeutics to Present at 17th Annual BIO CEO & Investor Conference "Business Wire" - 2/4/2015 9:12:00 AM
Ocata Therapeutics Appoints John Heffernan, Vice President of Manufacturing "Business Wire" - 2/3/2015 4:10:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/2/2015 4:08:38 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/2/2015 4:08:38 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/2/2015 4:08:38 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/2/2015 4:08:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/2/2015 4:06:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/19/2014 4:32:35 PM
ddls   Monday, 02/24/14 10:11:36 AM
Re: crawford2012 post# 61362
Post # of 82858 
Advanced Cell Technology Shelves Myoblast Program...

"What most don't realize, is that they had a trial (Myoblast) that was approved for phase II trials back in 2008. The cost to start it up was estimated @ 15M, but instead of funding the heart trials, they wasted $$$ on expensive administration, and free stock handouts to themselves worth millions. Then they had the audacity to blame the government, religious groups, and eventually the investors for playing a role in their struggles.

They were also supposed to have had trials that were blood related (HG) since 2008, but that was all a farce as well and the company simply used this to hype up investors into thinking that big things were right around the corner. In reality, the only thing big in their plans was diluting shareholders with toxic financing and poor management decisions."


ACTC

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist